vs
Axe Compute Inc.（AGPU）与捷迈邦美（ZBH）财务数据对比。点击上方公司名可切换其他公司
捷迈邦美的季度营收约是Axe Compute Inc.的258669.6倍（$2.2B vs $8.7K）。捷迈邦美净利率更高（6.2% vs -1740028.0%，领先1740034.2%）。捷迈邦美同比增速更快（10.9% vs -1.3%）。过去两年Axe Compute Inc.的营收复合增速更高（33.6% vs 9.0%）
捷迈邦美是一家美国上市的医疗设备企业，1927年成立，最初以生产铝制夹板为核心业务，总部设于印第安纳州华沙市，是当地医疗设备产业集群的核心成员，在全球骨科医疗器械领域拥有较高知名度。
AGPU vs ZBH — 直观对比
营收规模更大
ZBH
是对方的258669.6倍
$8.7K
营收增速更快
ZBH
高出12.2%
-1.3%
净利率更高
ZBH
高出1740034.2%
-1740028.0%
两年增速更快
AGPU
近两年复合增速
9.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.7K | $2.2B |
| 净利润 | $-150.9M | $139.4M |
| 毛利率 | — | 64.7% |
| 营业利润率 | -1990880.1% | 6.9% |
| 净利率 | -1740028.0% | 6.2% |
| 营收同比 | -1.3% | 10.9% |
| 净利润同比 | -6856.6% | -41.8% |
| 每股收益（稀释后） | — | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGPUZBH
| Q4 25 | $8.7K | $2.2B | ||
| Q3 25 | $3.6K | $2.0B | ||
| Q2 25 | $2.7K | $2.1B | ||
| Q1 25 | $110.3K | $1.9B | ||
| Q4 24 | $8.8K | $2.0B | ||
| Q3 24 | $3.9K | $1.8B | ||
| Q2 24 | $67.3K | $1.9B | ||
| Q1 24 | $4.9K | $1.9B |
净利润AGPUZBH
| Q4 25 | $-150.9M | $139.4M | ||
| Q3 25 | $-77.7M | $230.9M | ||
| Q2 25 | $-2.1M | $152.8M | ||
| Q1 25 | $-2.4M | $182.0M | ||
| Q4 24 | $-2.2M | $239.5M | ||
| Q3 24 | $-3.1M | $249.1M | ||
| Q2 24 | $-3.2M | $242.8M | ||
| Q1 24 | $-4.2M | $172.4M |
毛利率AGPUZBH
| Q4 25 | — | 64.7% | ||
| Q3 25 | -131.0% | 72.1% | ||
| Q2 25 | -579.4% | 71.5% | ||
| Q1 25 | 59.1% | 71.2% | ||
| Q4 24 | -250.5% | 71.0% | ||
| Q3 24 | -186.1% | 70.5% | ||
| Q2 24 | 79.4% | 71.5% | ||
| Q1 24 | -361.8% | 72.9% |
营业利润率AGPUZBH
| Q4 25 | -1990880.1% | 6.9% | ||
| Q3 25 | -90654.1% | 17.6% | ||
| Q2 25 | -99174.8% | 14.4% | ||
| Q1 25 | -2073.3% | 15.3% | ||
| Q4 24 | -23848.9% | 19.2% | ||
| Q3 24 | -55296.7% | 15.3% | ||
| Q2 24 | -3664.6% | 18.1% | ||
| Q1 24 | -73734.7% | 14.1% |
净利率AGPUZBH
| Q4 25 | -1740028.0% | 6.2% | ||
| Q3 25 | -2146264.3% | 11.5% | ||
| Q2 25 | -77198.4% | 7.4% | ||
| Q1 25 | -2214.6% | 9.5% | ||
| Q4 24 | -24676.9% | 11.8% | ||
| Q3 24 | -79208.9% | 13.7% | ||
| Q2 24 | -4730.1% | 12.5% | ||
| Q1 24 | -86843.2% | 9.1% |
每股收益（稀释后）AGPUZBH
| Q4 25 | — | $0.71 | ||
| Q3 25 | — | $1.16 | ||
| Q2 25 | — | $0.77 | ||
| Q1 25 | — | $0.91 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | — | $1.23 | ||
| Q2 24 | — | $1.18 | ||
| Q1 24 | — | $0.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.8M | $591.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $47.7M | $12.7B |
| 总资产 | $52.9M | $23.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGPUZBH
| Q4 25 | $10.8M | $591.9M | ||
| Q3 25 | $181.7K | $1.3B | ||
| Q2 25 | $506.1K | $556.9M | ||
| Q1 25 | $3.1M | $1.4B | ||
| Q4 24 | $611.8K | $525.5M | ||
| Q3 24 | $3.1M | $569.0M | ||
| Q2 24 | $5.3M | $420.1M | ||
| Q1 24 | $5.2M | $393.0M |
股东权益AGPUZBH
| Q4 25 | $47.7M | $12.7B | ||
| Q3 25 | $-77.4M | $12.8B | ||
| Q2 25 | $-1.7M | $12.5B | ||
| Q1 25 | $-145.8K | $12.4B | ||
| Q4 24 | $-202.6K | $12.5B | ||
| Q3 24 | $2.0M | $12.4B | ||
| Q2 24 | $4.1M | $12.7B | ||
| Q1 24 | $4.1M | $12.6B |
总资产AGPUZBH
| Q4 25 | $52.9M | $23.1B | ||
| Q3 25 | $3.1M | $23.5B | ||
| Q2 25 | $3.4M | $22.9B | ||
| Q1 25 | $5.9M | $22.2B | ||
| Q4 24 | $5.0M | $21.4B | ||
| Q3 24 | $7.5M | $21.7B | ||
| Q2 24 | $10.6M | $21.5B | ||
| Q1 24 | $10.6M | $21.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.9M | $517.4M |
| 自由现金流经营现金流 - 资本支出 | — | $442.6M |
| 自由现金流率自由现金流/营收 | — | 19.7% |
| 资本支出强度资本支出/营收 | 0.0% | 3.3% |
| 现金转化率经营现金流/净利润 | — | 3.71× |
| 过去12个月自由现金流最近4个季度 | — | $1.5B |
8季度趋势，按日历期对齐
经营现金流AGPUZBH
| Q4 25 | $-3.9M | $517.4M | ||
| Q3 25 | $-1.7M | $418.7M | ||
| Q2 25 | $-3.3M | $378.2M | ||
| Q1 25 | $-985.8K | $382.8M | ||
| Q4 24 | $-2.1M | $506.3M | ||
| Q3 24 | $-2.5M | $395.7M | ||
| Q2 24 | $-3.2M | $369.4M | ||
| Q1 24 | $-3.4M | $228.0M |
自由现金流AGPUZBH
| Q4 25 | — | $442.6M | ||
| Q3 25 | — | $363.7M | ||
| Q2 25 | — | $328.1M | ||
| Q1 25 | — | $338.2M | ||
| Q4 24 | $-2.1M | $454.8M | ||
| Q3 24 | — | $351.2M | ||
| Q2 24 | — | $316.7M | ||
| Q1 24 | $-3.4M | $172.9M |
自由现金流率AGPUZBH
| Q4 25 | — | 19.7% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 15.8% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | -23429.1% | 22.5% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | -70379.8% | 9.2% |
资本支出强度AGPUZBH
| Q4 25 | 0.0% | 3.3% | ||
| Q3 25 | 0.0% | 2.7% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.0% | 2.3% | ||
| Q4 24 | 73.7% | 2.5% | ||
| Q3 24 | 0.0% | 2.4% | ||
| Q2 24 | 0.0% | 2.7% | ||
| Q1 24 | 62.4% | 2.9% |
现金转化率AGPUZBH
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | 1.81× | ||
| Q2 25 | — | 2.48× | ||
| Q1 25 | — | 2.10× | ||
| Q4 24 | — | 2.11× | ||
| Q3 24 | — | 1.59× | ||
| Q2 24 | — | 1.52× | ||
| Q1 24 | — | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGPU
暂无分部数据
ZBH
| Knees | $911.0M | 41% |
| SET | $587.6M | 26% |
| Hips | $555.4M | 25% |
| Technology And Data Bone Cement And Surgical | $189.8M | 8% |
